A Korean Cohort Study of TDF Rescue Therapy for Difficult-to-treat CHB Patients: a Comparison Between TDF Monotherapy and TDF-based Combination Therapy
N/A
Antiviral resistance remains an important issue for long-term NA therapy. F...
Status
Completed
Location
Department of Internal Medicine, Yonsei University College of Medicine
Start Date
2014-05-12
Trial ID
NCT02019966
A Phase II Study of Siltuximab for CRS/ICANs After CAR-T in Multiple Myeloma
PHASE2
This is a prospective Phase II study evaluating Siltuximab for CRS and ICAN...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
A Korean Study of Efficacy and Safety of Aprepitant-based Triple Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in the First Cycle of Moderately Emetogenic Chemotherapy (Non-doxorubicin Hydrochloride [Adriamycin] and Cyclophosphamide Regimens) (MK-0869-225) (KMEC)
PHASE4
This is an efficacy and safety study to compare aprepitant with ondansetron...